HENRY WYNN: Open Payments
NPI 1053353805 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$527 in 17 payments from 10 companies in 2025. Trend: 2023 $1,443 · 2024 $811 · 2025 $527
Food & beverage: $527
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 1 | $145 |
| Alnylam Pharmaceuticals Inc. | 2 | $70 |
| Amgen Inc. | 2 | $55 |
| E.R. Squibb & Sons, L.L.C. | 3 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| Tactile Systems Technology Inc | 1 | $41 |
| Baxter Healthcare | 2 | $41 |
| PFIZER INC. | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $16 |
Products named: Assure WCD, AMVUTTRA, REPATHA, CAMZYOS, LEQVIO, Flexitouch Plus, ELIQUIS, JARDIANCE.
Industry payments across MD — which companies pay providers there.
